Yuming Guo

机构：Beijing Biocytogen (China)

发表论文 3 篇 · 总被引 10 次 · h-index 2

代表论文

• Abstract LB215: A first-in-class anti-TROP2/EGFR bispecific antibody-drug conjugate, DM001, exhibits potent anti-tumor efficacy (2023 · Cancer Research · 被引 5)
• Abstract 2977: A first-in-class anti-HER2/TROP2 bispecific antibody-drug conjugate (YH012) exhibits potent anti-tumor efficacy (2023 · Cancer Research · 被引 5)
• 1152 DM001: A novel bispecific ADC targeting TROP2 and EGFR with potent anti-tumor efficacy in PDX models (2023 · Regular and Young Investigator Award Abstracts)